Skip to content
Nonprofiteer
← NATIONAL PSORIASIS FOUNDATION

Form 990 for tax year 2023

Filed by NATIONAL PSORIASIS FOUNDATION.

Totals

Total revenue
$11,595,768
Total expenses
$12,586,852
Contributions and grants received
$10,084,711
Grants paid
$2,930,843
Program service revenue
$1,933,982
Investment income
$207,360
Other revenue
-$630,285
Total assets, end of year
$14,679,906
Total liabilities, end of year
$5,940,214
Net assets or fund balances, end of year
$8,739,692
Program services expenses (Part IX)
$9,692,145
Management and general expenses
$1,439,471
Fundraising expenses
$1,455,236
Program service expenses (Part III)
$9,692,145

Program services were 77.0% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1a · Federated campaigns

    $174

  • 1b · Membership dues

    $30,933

  • 1c · Fundraising events

    $2,702,831

  • 1e · Government grants (contributions)

    $395,842

  • 1f · All other contributions, gifts and grants

    $6,954,931

  • 1g · Noncash contributions included above

    $25,559

  • 2a · Program service revenue: ADVERTISING INCOME

    total $1,016,015 · unrelated business $1,016,015

  • 2b · Program service revenue: PRODUCT CERTIFICATION

    total $484,392 · related or exempt $484,392

  • 2c · Program service revenue: PATIENT RECRUITMENT

    total $369,983 · related or exempt $369,983

  • 2d · Program service revenue: ROYALTIES

    total $38,299 · related or exempt $38,299

  • 2e · Program service revenue: SCIENTIFIC ADVISORY

    total $12,000 · related or exempt $12,000

  • 2f · All other program service revenue

    total $13,293 · related or exempt $13,293

  • 3 · Investment income

    total $318,103 · excluded $318,103

  • 7a · Gross sales of assets other than inventory

    securities $418,929

  • 7b · Less cost or other basis and sales expenses

    securities $529,672

  • 7c · Gain or loss

    securities -$110,743

  • 7d · Net gain or loss

    total -$110,743 · excluded -$110,743

  • 8a · Fundraising events: gross income

    $0

  • 8a · Fundraising events: contributions included on line 1c

    $2,702,831

  • 8b · Fundraising events: direct expenses

    $630,547

  • 8c · Net income from fundraising events

    total -$630,547 · excluded -$630,547

  • 10a · Gross sales of inventory

    $262

  • 10b · Cost of goods sold

    $0

  • 10c · Net income from sales of inventory

    total $262 · related or exempt $262

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $2,293,189 · program services $2,293,189

  • 3 · Grants to foreign organizations and individuals

    total $637,654 · program services $637,654

  • 5 · Compensation of officers, directors and key employees

    total $1,143,882 · program services $814,346 · management and general $209,199 · fundraising $120,337

  • 7 · Other salaries and wages

    total $4,250,383 · program services $3,025,907 · management and general $777,332 · fundraising $447,144

  • 8 · Pension plan contributions

    total $191,293 · program services $136,184 · management and general $34,985 · fundraising $20,124

  • 9 · Other employee benefits

    total $333,980 · program services $237,765 · management and general $61,080 · fundraising $35,135

  • 10 · Payroll taxes

    total $393,380 · program services $280,053 · management and general $71,943 · fundraising $41,384

  • 11b · Fees: legal

    total $48,101 · program services $32,709 · management and general $9,620 · fundraising $5,772

  • 11c · Fees: accounting

    total $18,605 · program services $12,651 · management and general $3,721 · fundraising $2,233

  • 11d · Fees: lobbying

    total $245,323 · program services $245,323

  • 11e · Fees: professional fundraising services

    total $233,613 · fundraising $233,613

  • 11f · Fees: investment management

    total $31,857 · management and general $31,857

  • 11g · Fees: other

    total $407,613 · program services $373,998 · management and general $20,422 · fundraising $13,193

  • 12 · Advertising and promotion

    total $278,941 · program services $267,836 · fundraising $11,105

  • 13 · Office expenses

    total $67,711 · program services $34,320 · management and general $6,921 · fundraising $26,470

  • 16 · Occupancy

    total $155,087 · program services $110,409 · management and general $28,363 · fundraising $16,315

  • 19 · Conferences, conventions and meetings

    total $918,956 · program services $691,360 · management and general $11,519 · fundraising $216,077

  • 22 · Depreciation, depletion and amortization

    total $50,214 · program services $35,748 · management and general $9,183 · fundraising $5,283

  • 23 · Insurance

    total $57,871 · program services $41,199 · management and general $10,584 · fundraising $6,088

  • 24a · Other expenses: DUES AND SUBSCRIPTIONS

    total $363,879 · program services $271,326 · management and general $25,987 · fundraising $66,566

  • 24b · Other expenses: PRINTING AND POSTAGE

    total $205,310 · program services $93,176 · management and general $2,181 · fundraising $109,953

  • 24c · Other expenses: TAXES

    total $92,486 · management and general $92,486

  • 24d · Other expenses: BANK FEES

    total $76,714 · management and general $20,293 · fundraising $56,421

  • 24e · All other expenses

    total $90,810 · program services $56,992 · management and general $11,795 · fundraising $22,023

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $2,155,746 · end of year $1,023,562

  • 3 · Pledges and grants receivable

    beginning of year $1,788,781 · end of year $2,461,795

  • 4 · Accounts receivable

    beginning of year $703,034 · end of year $443,481

  • 8 · Inventories for sale or use

    beginning of year $4,370 · end of year $2,630

  • 9 · Prepaid expenses and deferred charges

    beginning of year $152,539 · end of year $226,382

  • 10a · Land, buildings and equipment: cost or other basis

    $474,439

  • 10b · Land, buildings and equipment: accumulated depreciation

    $250,562

  • 10c · Land, buildings and equipment, net

    beginning of year $385,368 · end of year $223,877

  • 11 · Investments: publicly traded securities

    beginning of year $8,511,304 · end of year $9,620,108

  • 15 · Other assets

    beginning of year $115,884 · end of year $678,071

  • 17 · Accounts payable and accrued expenses

    beginning of year $617,899 · end of year $952,666

  • 18 · Grants payable

    beginning of year $3,845,657 · end of year $4,024,290

  • 19 · Deferred revenue

    beginning of year $168,500 · end of year $121,375

  • 25 · Other liabilities

    beginning of year $166,320 · end of year $841,883

  • 27 · Net assets without donor restrictions

    beginning of year $5,506,333 · end of year $5,271,417

  • 28 · Net assets with donor restrictions

    beginning of year $3,512,317 · end of year $3,468,275

Mission and programs · 2023

Mission

THE NATIONAL PSORIASIS FOUNDATION PROVIDES PEOPLE WITH PSORIASIS AND PSORIATIC ARTHRITIS THE SERVICES THEY NEED TO BEST MANAGE THEIR CONDITION, WHILE PROMOTING RESEARCH TO FIND A CURE.

Activities or mission (Part I)

TO DRIVE EFFORTS TO CURE PSORIATIC DISEASE AND IMPROVE THE LIVES OF THOSE AFFECTED.

  • RESEARCHNPF CONTINUED TO LEAD COLLABORATIVE, TRANSFORMATIONAL RESEARCH BY ENSURING THAT FUNDING EXTRAMURAL RESEARCH REMAINED A PRIORITY. IN FY 2024, NPF INVESTED OVER $2.9M IN RESEARCH GRANTS AND FELLOWSHIP AWARDS. INTRODUCED IN 2020, THE NPF HAS INVESTED OVER $4M TOWARDS THE PSORIASIS PREVENTION INITIATIVE GRANT, A STUDY AIMED AT PREVENTING THE ONSET ON CARDIOVASCULAR DISEASE IN PEOPLE WITH PSORIATIC DISEASE, AND TO PROVIDE, TIMELY, ADEQUATE TREATMENT FOR THOSE DEEMED TO BE AT HIGH RISK OF DEVELOPING CARDIOVASCULAR DISEASE. IN FY 2023, THE PILOT PHASE OF THE UNIVERSITY OF PENNSYLVANIA-LED STUDY ON CVD CONCLUDED AND PLANNING BEGAN FOR THE LAUNCH OF THE FULL STUDY. THIS UNIQUE, SCALABLE MODEL THAT TESTS CARE COORDINATION ACROSS DERMATOLOGISTS AND PRIMARY CARE PROVIDERS SAW PROMISING EARLY RESULTS IN THE PILOT STUDY. OF THE 25% OF PEOPLE IN PHASE ONE WHO WERE IDENTIFIED AS HAVING AS HIGH RISK FOR CARDIOVASCULAR DISEASE, 85% FOLLOWED THROUGH WITH AN APPOINTMENT WITH THEIR HEALTH CARE PROVIDER TO ADDRESS CARDIOVASCULAR DISEASE. THE PSA DIAGNOSTIC TEST GRANT WAS LAUNCHED IN 2020 WITH THE GOAL OF ADVANCING THE DEVELOPMENT OF THE FIRST DIAGNOSTIC TEST FOR PSA, REDUCING GUESSWORK AND LONG DELAYS IN DIAGNOSIS AND TREATMENT. AT THE CONCLUSION OF THE STUDY THIS FISCAL YEAR, KEY FINDINGS OF THE RESEARCH EVIDENCING THE CRITICAL ADVANCEMENTS IN UNDERSTANDING THE DISEASE TO HELP INFORM THE WORK OF OTHER RESEARCHERS AND CLINICIANS WERE PUBLISHED IN SCIENCE IMMUNOLOGY. THE NPF CONTINUED TO COLLABORATE WITH PUBLIC-PRIVATE PARTNERS IN THE ACCELERATED MEDICINES PARTNERSHIP FOR AUTOIMMUNE AND IMMUNE-MEDIATED DISEASES INITIATIVE, PUBLISHED SEVERAL ABSTRACTS AND PAPERS, AND BROUGHT THE INTERNALLY GENERATED DATA TO THE COMMUNITY.

    Expenses $3,846,872 · Grants $2,930,843

  • PROFESSIONAL EDUCATIONNPF CONTINUED TO EXPAND AND STRENGTHEN MEDICAL EDUCATION PROGRAMMING TARGETING HEALTH CARE PROVIDERS AT ALL LEVELS AND STAGES OF CAREER. THE 25TH ANNUAL NPF RESIDENTS' MEETING OFFERED DERMATOLOGY RESIDENTS THE LATEST IN PSORIATIC DISEASE TREATMENT PRESENTED BY EXPERTS IN THE FIELD. NPF ALSO LAUNCHED A COMPLIMENTARY RHEUMATOLOGY FELLOWS MEETING TO OFFER EDUCATION TO NEXT GENERATION RHEUMATOLOGISTS AND DEVELOP THE RELATIONSHIPS BETWEEN THESE FUTURE CARE COLLABORATORS. THE NPF HOSTED ITS BI-ANNUAL NPF RESEARCH SYMPOSIUM: A CURE FOR ALL, THE NATION'S PREMIER PSORIATIC DISEASE RESEARCH EVENT WHICH FEATURED SPEAKERS ON A WIDE ARRAY OF CURRENT TOPICS FROM THE PSORIASIS TO PSA TRANSITION TO THE RESULTS OF A NOVEL KNOCKOUT STUDY AIMING TO CLEAR PSORIASIS SYMPTOMS WITH EARLY AGGRESSIVE BIOLOGIC TREATMENT.THROUGH ITS DEDICATION TO EDUCATING HEALTH CARE PROVIDERS ON PSORIATIC DISEASE AND ITS RELATED DISEASES, NPF HAS EARNED ACCREDITATION AS A PROVIDER OF CONTINUING MEDICAL EDUCATION. IT'S PART OF OUR EFFORTS TO ENSURE ALL DIFFERENT TYPES OF HEALTH CARE PROVIDERS UNDERSTAND THIS COMPLICATED DISEASE. NPF OFFERS THE PSOUND BYTES CONTINUING MEDICAL EDUCATION PODCASTS, WEBINARS, AND IN-PERSON CLASSES AND SEMINARS FOR A WIDE RANGE OF AUDIENCES AND PUBLISHES THE JOURNAL OF PSORIASIS AND PSORIATIC ARTHRITIS, A PEER REVIEWED OUTLET FEATURING CME ARTICLES.

    Expenses $1,321,080 · Revenue $12,000

  • ADVOCACYNPF CONTINUED TO ADVOCATE ON BOTH STEP THERAPY AND COPAY ACCUMULATOR ADJUSTMENT PROGRAMS TO ENSURE PATIENTS HAVE AFFORDABLE ACCESS TO THERAPIES. NPF ALSO LEVERAGED THOUSANDS OF ADVOCATES TO WORK FOR HEALTH INSURANCE COVERAGE IMPROVEMENTS FOR THE MILLIONS OF PEOPLE LIVING WITH PSORIATIC DISEASE, WHILE ALSO WORKING TO IMPROVE THE SAFETY AND AFFORDABILITY OF PSORIASIS AND PSA TREATMENTS AND INCREASING FEDERAL SUPPORT FOR PSORIATIC DISEASE RESEARCH.

    Expenses $1,063,418

  • EDUCATION, OUTREACH, AND PATIENT SERVICESTHE NPF IS PROUD TO HAVE PUBLISHED THE FIRST EVER PSORIASIS HEALTH INDICATOR REPORT. THIS SET OF DATA ABOUT PSORIATIC DISEASE AND ITS IMPACTS WAS MADE POSSIBLE BY A PARTNERSHIP WITH THE CENTERS FOR DISEASE CONTROL AND THROUGH THE CONTRIBUTIONS OF TODAY'S LEADERS IN DERMATOLOGY AND RHEUMATOLOGY RESEARCH AND CLINICAL CARE. THE PSORIASIS HEALTH INDICATOR REPORT PROVIDES INFORMATION NEEDED TO EDUCATE THE GENERAL PUBLIC, HEALTH OFFICIALS, AND HEALTH CARE PROVIDERS ABOUT KEY ISSUES AND CHALLENGES AFFECTING THE MORE THAN 8 MILLION PEOPLE IN THE U.S. WHO LIVE WITH THIS DISEASE. SINCE 2016, NPF'S PATIENT NAVIGATION CENTER HAS SUPPORTED OVER 90,000 PATIENTS AND THEIR CAREGIVERS WITH FREE, PERSONALIZED SUPPORT DESIGNED TO HELP THEM UNDERSTAND PSORIATIC DISEASE AND TREATMENT OPTIONS, NAVIGATE INSURANCE CHALLENGES, AND FIND THE APPROPRIATE HEALTH CARE PROVIDER. NPF ADVANCE MAGAZINE CONTINUED TO PROVIDE THE LATEST INFORMATION, STORIES, AND RESOURCES FIVE TIMES ANNUALLY FOR OVER 25,000 PRINT SUBSCRIBERS AND HUNDREDS OF THOUSANDS OF ONLINE READERS. EACH WEEK, MORE THAN 283,000 PEOPLE RECEIVED ADVANCE WEEKLY, THE OFFICIAL PATIENT-FOCUSED E-NEWSLETTER OF NPF.

    Expenses $3,460,775 · Revenue $906,229

As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Leah McCormick Howard

    PRESIDENT/CEO

    Total calculated
    $339,959
    From this org
    $304,524
    From related orgs
    $0
    Other
    $35,435
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $304,524
    Bonus
    $0
    Other
    $0
    Deferred
    $32,715
    Nontaxable benefits
    $2,720
    Filer's total
    $339,959
  • Randy Beranek Thru Dec 2021

    FORMER PRESIDENT/CEO

    Total calculated
    $53,802
    From this org
    $53,802
    From related orgs
    $0
    Other
    $0
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $0
    Bonus
    $0
    Other
    $53,802
    Deferred
    $0
    Nontaxable benefits
    $0
    Filer's total
    $53,802
  • Ronald Goldsman

    CHIEF FINANCIAL OFFICER

    Total calculated
    $232,904
    From this org
    $214,283
    From related orgs
    $0
    Other
    $18,621
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $214,283
    Bonus
    $0
    Other
    $0
    Deferred
    $17,024
    Nontaxable benefits
    $1,597
    Filer's total
    $232,904
  • Jennifer Fagerstrom

    CHIEF REVENUE OFFICER

    Total calculated
    $267,276
    From this org
    $227,737
    From related orgs
    $0
    Other
    $39,539
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $227,737
    Bonus
    $0
    Other
    $0
    Deferred
    $24,254
    Nontaxable benefits
    $15,285
    Filer's total
    $267,276
  • Guy Eakin

    CHIEF SCIENTIFIC & MEDICAL OFFICER

    Total calculated
    $165,816
    From this org
    $153,257
    From related orgs
    $0
    Other
    $12,559
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $153,257
    Bonus
    $0
    Other
    $0
    Deferred
    $6,563
    Nontaxable benefits
    $5,996
    Filer's total
    $165,816
  • Rene Islas

    CHIEF OF STAFF

    Total calculated
    $167,261
    From this org
    $140,595
    From related orgs
    $0
    Other
    $26,666
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $105,042
    Bonus
    $0
    Other
    $35,553
    Deferred
    $7,552
    Nontaxable benefits
    $19,114
    Filer's total
    $167,261
  • Jason Harris

    VICE PRESIDENT OF GOVERNMENT RELATIONS & ADVOCACY

    Total calculated
    $171,658
    From this org
    $153,312
    From related orgs
    $0
    Other
    $18,346
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $153,312
    Bonus
    $0
    Other
    $0
    Deferred
    $8,882
    Nontaxable benefits
    $9,464
    Filer's total
    $171,658
  • Katherine Southwick

    VICE PRESIDENT OF MARKETING & COMMUNICATIONS

    Total calculated
    $152,494
    From this org
    $136,394
    From related orgs
    $0
    Other
    $16,100
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $136,394
    Bonus
    $0
    Other
    $0
    Deferred
    $6,789
    Nontaxable benefits
    $9,311
    Filer's total
    $152,494
  • Breanna Baer

    VICE PRESIDENT, FIELD DEVELOPMENT & OPERATIONS

    Total calculated
    $163,489
    From this org
    $141,302
    From related orgs
    $0
    Other
    $22,187
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $141,302
    Bonus
    $0
    Other
    $0
    Deferred
    $7,450
    Nontaxable benefits
    $14,737
    Filer's total
    $163,489
  • Robert Friesel

    DIRECTOR OF RESEARCH & MEDICAL AFFAIRS

    Total calculated
    $146,601
    From this org
    $125,719
    From related orgs
    $0
    Other
    $20,882
    Hours/week
    40
  • Carol Ostrow

    CHAIR-ELECT

    Total calculated
    $0
    Hours/week
    1
  • Eyal Ofir

    VICE CHAIR

    Total calculated
    $0
    Hours/week
    1
  • Mike Refermat

    TREASURER

    Total calculated
    $0
    Hours/week
    1
  • Richard Seiden

    SECRETARY

    Total calculated
    $0
    Hours/week
    1
  • Ron Grau

    PAST CHAIR

    Total calculated
    $0
    Hours/week
    1
  • Jonathan Scott

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Larry Green MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Mary Carroll

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Michael Graff

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Mark Oberman

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Jason Lichten MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Pete Miller Thru March 2023

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Matthew T Kiselica

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • April Armstrong MD Thru June 2023

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Elaine Husni MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Valerie Harrison From June 2023

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Diana Sandler From June 2023

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1
  • Brian Janssen From June 2023

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Compensation committee
  • 3 · Written employment contract
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee
  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan

Answered no

  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments
  • 8 · Paid under the initial-contract exception

The filer's explanations (Part III)

PART I, LINES 4A-B
RANDY BERANAK RECEIVED A FINAL COMPENSATION PAYMENT OF $53,802 THAT WAS PAID OUT OVER TIME. EMPLOYER CONTRIBUTIONS TO 457(F): LEAH MCCORMICK HOWARD - $17,500 JENNIFER FAGERSTROM - $12,500 RONALD GOLDSMAN - $10,000

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

The 10 largest by cash amount. The API serves every itemized grant.

Fundraising and gaming

From Schedule G of this return, as filed.

Raised funds through (line 1)
mail, email, phone, in person, non-government grants, special fundraising events
Had an agreement with a professional fundraiser (line 2a)
Yes
Registered or licensed to solicit in (line 3)
AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NE, NV, NH, NJ, NM, NY, NC, ND, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA, WV, WI, WY

Professional fundraisers (line 2b)

Their names and addresses are not shown.

Activity Custody of contributions Gross receipts Kept by fundraiser To the organization
DIRECT MAIL No $403,454 $233,613 $169,841
Total, as filed $403,454 $233,613 $169,841

Fundraising events (Part II)

Part II has at most four columns: the two largest events, the rest together, and the total.

Line Event 1 PEER TO PEER (TAKE ACTION/TEAM NPF) Event 2 COMMIT TO CURE GALA Other events 1 events Total
Gross receipts (line 1) $905,365 $777,887 $1,019,579 $2,702,831
Less contributions (line 2) $905,365 $777,887 $1,019,579 $2,702,831
Gross income (line 3) — — — —
Cash prizes (line 4) — — — —
Noncash prizes (line 5) $11,505 $5,837 $6,634 $23,976
Rent and facility costs (line 6) $14,926 $28,577 $155,038 $198,541
Food and beverages (line 7) $7,773 $14,883 $80,742 $103,398
Entertainment (line 8) $13,209 $16,551 $41,586 $71,346
Other direct expenses (line 9) $56,584 $72,110 $104,592 $233,286
Direct expenses (line 10)
$630,547
Net income (line 11)
-$630,547

Activities outside the United States

From Schedule F of this return, as filed.

Offices (line 3c)
0
Employees, agents and contractors (line 3c)
0
Expenditures and investments (line 3c)
$637,654

At most 25 lines of each part are listed here. Schedule F names no grantee, so each line is a region and its money.

Activities by region (Part I)

Region Offices Employees Activity Specific services Expenditures
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 GRANT EXPENSES DISCOVERY AND EARLY CAREER RESEARCH GRANT $89,000
NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES 0 0 GRANT EXPENSES PSA DIAGNOSTIC AWARD $423,654
EAST ASIA AND THE PACIFIC 0 0 GRANT EXPENSE EARLY CAREER RESEARCH GRANT $50,000
MIDDLE EAST AND NORTH AFRICA 0 0 DISCOVERY GRANT DISCOVERY GRANT $75,000

Grants to organizations, by region (Part II)

The purpose of each grant is not shown.

Region Cash grants Manner of disbursement Noncash assistance Noncash description Valuation
MIDDLE EAST AND NORTH AFRICA $75,000 BANK DRAFT $0 — —
EUROPE (INCLUDING ICELAND & GREENLAND) $72,000 BANK DRAFT $0 — —
EUROPE (INCLUDING ICELAND & GREENLAND) $17,000 BANK DRAFT $0 — —
NORTH AMERICA (CANADA AND MEXICO, BUT NOT U.S.) $199,510 BANK DRAFT $0 — —
NORTH AMERICA (CANADA AND MEXICO, BUT NOT U.S.) $50,000 BANK DRAFT $0 — —
NORTH AMERICA (CANADA AND MEXICO, BUT NOT U.S.) $50,000 BANK DRAFT $0 — —
NORTH AMERICA (CANADA AND MEXICO, BUT NOT U.S.) $49,710 BANK DRAFT $0 — —
NORTH AMERICA (CANADA AND MEXICO, BUT NOT U.S.) $74,434 BANK DRAFT $0 — —
EAST ASIA AND THE PACIFIC $50,000 BANK DRAFT $0 — —
Grantees recognized as charities or with a 501(c)(3) equivalency letter (Part II line 2)
0
Other grantees (Part II line 3)
9
Transferred property to a foreign corporation during the year (line 1)
No
Had an interest in a foreign trust (line 2)
No
Owned an interest in a foreign corporation (line 3)
No
Was a shareholder of a passive foreign investment company or qualified electing fund (line 4)
No
Owned an interest in a foreign partnership (line 5)
No
Had operations in or related to a boycotting country (line 6)
No

Provenance

Return type
form_990
Tax year
2023
Filed
30 January 2025
IRS schema version
2023v6.0
Source object
202530319349300033

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.